Full Press Release Details
Biogen Shares Update on FDA Advisory Committee Meeting for Tofersen.
BIIB
Biogen Shares Update on FDA Advisory Committee Meeting for Tofersen
Key Takeaway: Biogen Shares Update on FDA Advisory Committee Meeting for Tofersen
Price reaction · baseline $285.77 (2023-01-20 close) · 1 other BIIB headline(s) in the window, move may be shared
day 0 close · peak
+2.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis